TJ266B - Application of acylfulvene analogues and pharmaceutical composition on their basis - Google Patents

Application of acylfulvene analogues and pharmaceutical composition on their basis

Info

Publication number
TJ266B
TJ266B TJ96000336A TJ96000336A TJ266B TJ 266 B TJ266 B TJ 266B TJ 96000336 A TJ96000336 A TJ 96000336A TJ 96000336 A TJ96000336 A TJ 96000336A TJ 266 B TJ266 B TJ 266B
Authority
TJ
Tajikistan
Prior art keywords
cell
acylfulvene
analogues
basis
application
Prior art date
Application number
TJ96000336A
Other languages
English (en)
Inventor
Michel J Kelner
Trevor C Mcmorris
Raymond Taetle
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of TJ266B publication Critical patent/TJ266B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/455—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation with carboxylic acids or their derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/65—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by splitting-off hydrogen atoms or functional groups; by hydrogenolysis of functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/683—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/737—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having three rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/94—Spiro compounds containing "free" spiro atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
TJ96000336A 1993-02-09 1994-02-02 Application of acylfulvene analogues and pharmaceutical composition on their basis TJ266B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/015,179 US5439936A (en) 1989-10-03 1993-02-09 Method of treating certain tumors using illudin analogs
PCT/US1994/001232 WO1994018151A1 (en) 1993-02-09 1994-02-02 Acylfulvene analogues as antitumor agents

Publications (1)

Publication Number Publication Date
TJ266B true TJ266B (en) 2000-08-07

Family

ID=21769946

Family Applications (1)

Application Number Title Priority Date Filing Date
TJ96000336A TJ266B (en) 1993-02-09 1994-02-02 Application of acylfulvene analogues and pharmaceutical composition on their basis

Country Status (22)

Country Link
US (3) US5439936A (de)
EP (1) EP0683762B1 (de)
JP (1) JP3908270B2 (de)
KR (1) KR100311327B1 (de)
CN (1) CN1046934C (de)
AT (1) ATE174894T1 (de)
AU (1) AU676889B2 (de)
BR (1) BR9405689A (de)
CA (1) CA2155329C (de)
CZ (1) CZ288596B6 (de)
DE (1) DE69415507T2 (de)
DK (1) DK0683762T3 (de)
ES (1) ES2125441T3 (de)
GR (1) GR3029736T3 (de)
HU (1) HU220059B (de)
MD (1) MD1418G2 (de)
NO (1) NO318648B1 (de)
NZ (1) NZ262282A (de)
PL (1) PL175024B1 (de)
RU (1) RU2145849C1 (de)
TJ (1) TJ266B (de)
WO (1) WO1994018151A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5932553A (en) * 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
US7141603B2 (en) * 1999-02-19 2006-11-28 The Regents Of The University California Antitumor agents
US6025328A (en) * 1998-02-20 2000-02-15 The Regents Of The University Of California Antitumor agents
US7015247B2 (en) * 2000-10-12 2006-03-21 Alvin Guttag Ibuprofen-aspirin, hydroxymethylacylfulvene analogs and L-sugar illudin analogs
US6436916B1 (en) 2000-10-12 2002-08-20 Alvin Guttag Ibuprofen-aspirin and hydroxymethylacylfulvene analogs
CA2571421A1 (en) 2004-06-24 2006-01-05 Nicholas Valiante Compounds for immunopotentiation
EP1909783B1 (de) * 2005-08-03 2011-10-12 The Regents of the University of California Illudin-analoga als krebsmittel
EP2389171B1 (de) * 2009-01-26 2016-03-30 Taipei Medical University Verwendung von pterosinverbindungen zur behandlung von diabetes und adipositas
US10285955B2 (en) 2014-04-10 2019-05-14 Af Chemicals, Llc Affinity medicant conjugate
CA3194672A1 (en) 2014-04-10 2015-10-15 Af Chemicals, Llc Affinity medicant conjugates
US11135182B2 (en) 2014-04-10 2021-10-05 Af Chemicals, Llc Affinity medicant conjugates
CN106083953A (zh) * 2016-06-15 2016-11-09 成都医学院 一种从蕨菜中提取原蕨苷以及制备高纯度原蕨苷的方法
WO2018170230A1 (en) * 2017-03-15 2018-09-20 Memorial Sloan Kettering Cancer Center Diagnosis & treatment of ercc3-mutant cancer
WO2020051222A1 (en) * 2018-09-04 2020-03-12 Lantern Pharma Inc. Illudin analogs, uses thereof, and methods for synthesizing the same
EP3667323A1 (de) 2018-12-11 2020-06-17 Kelner, Michael Verfahren, zusammensetzungen und vorrichtungen zur behandlung von krebs mit illudofulvenen
RU2738848C1 (ru) * 2019-10-24 2020-12-17 Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида
EP4035684A1 (de) 2019-11-25 2022-08-03 AF Chemical LLC Affinitäts-illudofulven-konjugate
US11591295B2 (en) 2019-11-25 2023-02-28 Af Chemicals Llc Affinity illudofulvene conjugates
CN112972443A (zh) * 2021-03-29 2021-06-18 杭州添帆生物科技有限公司 一种抗癌药物及其应用
WO2023239821A2 (en) * 2022-06-07 2023-12-14 Lantern Pharma Inc. Treating cancers with combinations of acylfulvenes with ibrutinib or bortezomib
WO2024016014A2 (en) * 2022-07-15 2024-01-18 Lantern Pharma Inc. Method for treating breast cancers and parp resistant breast cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2530543C (en) * 1989-10-03 2008-04-01 The Regents Of The University Of California Illudin analogs as anti-tumor agents
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
FI85318C (fi) * 1990-08-14 1992-03-25 Tecnomen Oy Kompensering av felet i en klockas gaong.
JPH06223404A (ja) * 1993-01-25 1994-08-12 Mitsubishi Kasei Corp 光学的情報記録用媒体

Also Published As

Publication number Publication date
AU6170094A (en) 1994-08-29
JPH08506812A (ja) 1996-07-23
PL175024B1 (pl) 1998-10-30
PL310159A1 (en) 1995-11-27
US5523490A (en) 1996-06-04
NO953099L (no) 1995-10-09
HU220059B (hu) 2001-10-28
US5563176A (en) 1996-10-08
WO1994018151A1 (en) 1994-08-18
NZ262282A (en) 1997-06-24
NO318648B1 (no) 2005-04-25
HUT72450A (en) 1996-04-29
GR3029736T3 (en) 1999-06-30
MD960212A (en) 1999-01-31
EP0683762B1 (de) 1998-12-23
EP0683762A1 (de) 1995-11-29
BR9405689A (pt) 1995-11-21
MD1418F2 (en) 2000-02-29
US5439936A (en) 1995-08-08
HU9502358D0 (en) 1995-10-30
ES2125441T3 (es) 1999-03-01
JP3908270B2 (ja) 2007-04-25
NO953099D0 (no) 1995-08-07
CN1119854A (zh) 1996-04-03
AU676889B2 (en) 1997-03-27
CZ288596B6 (cs) 2001-07-11
KR100311327B1 (ko) 2001-12-28
CA2155329C (en) 2006-08-15
RU2145849C1 (ru) 2000-02-27
MD1418G2 (ro) 2000-10-31
CN1046934C (zh) 1999-12-01
CA2155329A1 (en) 1994-08-18
DK0683762T3 (da) 1999-08-23
DE69415507T2 (de) 1999-08-12
CZ198695A3 (en) 1996-01-17
ATE174894T1 (de) 1999-01-15
DE69415507D1 (de) 1999-02-04

Similar Documents

Publication Publication Date Title
TJ266B (en) Application of acylfulvene analogues and pharmaceutical composition on their basis
AU539976B2 (en) Therapeutically active compounds
GEP20012376B (en) Bicyclic Pyrimidine Derivatives Capable of InhibitingTyrosine Kinases of the Epidermal Growth Factor, Pharmaceutical Composition Containing the Same and Methods for Treatment
CA2029678A1 (en) Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 14
AU586166B2 (en) Anti-inflammatory compounds compositions containing them and processes for their preparation
EP1484058A3 (de) Pharmazeutische Zubereitung zur Hemmung von Gen-Expression sowie zur Induktion der Differentiation bei nicht-bösartigen Zellen
ZA854857B (en) Tropical treatment and composition
ATE240344T1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
MY121623A (en) Methods of preventing breast cancer.
NZ511280A (en) Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
WO1994002145A3 (en) 2-aryl-4-quinolones as antitumor compounds
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
MX9702253A (es) Nuevos estrenos para inducir efectos hipotalamicos
JPS57106618A (en) Anticancer agent consisting of polyprenyl compound
AU6826887A (en) 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
PH21295A (en) Octahydroindolizine compounds useful as analgesics
IL112110A0 (en) Octahydro-1h-isoindoles and pharmaceutical compositions containing them
RU94044323A (ru) Средство ингибирования навязчиво-компульсивных состояний и расстройств потребления
GB1322640A (en) Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon
IE790108L (en) Isoquinoline compounds
WO1998013063A8 (en) Cyclic peptide antitumor agent from an ascidian
ES8303297A1 (es) Un procedimiento para la preparacion de un nuevo reptido activo.
JPS54151133A (en) Antitumorigenic agent
EP0654269A4 (de) Medizinische zusammensetzung zur hemmung von krebsmetastasierung in die leber und medizinische zusammensetzung zur behandlung des hepatoms.
ES540841A0 (es) Un procedimiento compuesto de espiro 2h-1,4-benzodioxepin-3 (5h)4'-piperidina y -3'-pirrolidina